Should you buy, sell or hold Eicher Motors, Grasim, Bharat Forge, Siemens shares? Heres what analysts suggest
Most brokerages remain positive on Eicher Motors after the auto major reported a 62 per cent jump in its quarterly profit.
A day after their quarterly earnings, brokerages have come out with their rating and target price on half-a-dozen stocks.
Among them, most brokerages remain positive on Eicher Motors after the auto major reported a 62 per cent jump in its quarterly profit. They are also upbeat on Grasim but divided on Bharat Forge and Siemens.
Here's what global brokerages make of some of the key stocks in focus today:
Most brokerages are upbeat on Royal Enfield maker Eicher Motors, while others gave either a Neutral or Hold rating on the stock.
CLSA expects RE volumes to see double-digit growth along with margin expansion through price hikes and operating leverage. Morgan Stanley mentioned the company gained market share after the launch of Hunter, but margins and market share are likely to peak in 2023.
Brokerages | Rating | Price Target |
CLSA | Buy | Rs 4007 |
Morgan Stanley | Equalweight | Rs 3553 |
JP Morgan | Neutral | Rs 3420 |
Jefferies | Buy | Rs 4250 |
CITI | Buy | Rs 4400 |
Nomura | Neutral | Rs 3264 |
HSBC | Hold | Rs 3300 |
Despite reporting a fall in standalone profit by 51 per cent for the December quarter, brokerages are bullish on Grasim.
Jefferies said the Aditya Birla Group company reported a large miss in Q3 EBITDA, however, progress is on track for the keenly watched paints segment, supposed to be launched in Q4FY24
Grasim’s standalone EBITDA missed estimated, mainly led by weakness in both VSF and chemicals businesses as both volumes & realizations surprised negatively, as per Morgan Stanley.
Brokerages | Rating | Price Target |
Morgan Stanley | Overweight | Rs 1960 |
Jefferies | Buy | Rs 2000 |
CITI | Buy | Rs 2125 |
Global brokerages are divided on Bharat Forge shares despite reporting better than estimated numbers for the December quarter of FY23. According to CLSA, the company beat standalone estimates and revenue rose on higher-than-expected shipments and export revenue.
Nomura gave a double downgrade on stock to Neutral from Buy as it expects a cyclical slowdown in traditional business likely.
Brokerages | Rating | Price Target |
CLSA | Outperform | Rs 964 |
JP Morgan | Neutral | Rs 875 |
Jefferies | Underperform | Rs 555 |
CITI | Sell | Rs 690 |
Nomura | Neutral | Rs 992 |
Nomura maintained a ‘neutral’ rating, while Macquarie had an ‘outperform’ stance on Siemens.
Brokerages | Rating | Price Target |
Nomua | Neutral | Rs 3008 |
Macquarie | Outperform | Rs 3550 |
ICICI Pru Life
Macquarie maintains an ‘outperform’ rating on ICICI Pru Life with a target price of Rs 580 per share. It said, the annual premium equivalent (APE) & value of new business (VNB) impact around 6 per cent but confident of bringing it down.
Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.